Sign in
Taking people in United StatesNo phase

Online Diet and Exercise Program for Men with Prostate Cancer on Hormone Therapy

Tests an online diet and strength program in men with prostate cancer on hormone therapy.

Key facts

Who runs it
OHSU Knight Cancer Institute
Where
Portland, United StatesSee the site
Trial code
Registry title
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Status
Recruiting
People taking part
250 people, planned
Started
12 Mar 2024
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Internet-Based Exercise Intervention
  • Internet-Based Diet Intervention
  • Education Intervention
Record updated
8 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men with prostate cancer who had hormone treatment (ADT), are overweight or obese, and show signs of frailty. It tests an online weight loss and strength training program.

Age
18 years or older
Sex
All sexes
Disease stage
Prostate cancer confirmed by tissue testing; radiotherapy, chemotherapy or surgery finished more than 6 weeks ago; no plan to start further chemotherapy or radiotherapy within 6 months. Body mass index above 25 kg/m2 up to 50, and three or more signs of frailty (weakness, slowness, fatigue, inactivity, illness).
Earlier treatment
Had at least 6 months of ADT at any time in the past 10 years. Not currently in a structured diet or strength training program.

Main reasons for not taking part

  • Unintentional weight loss of more than 5% in the last year
  • Medical reason not to do moderate exercise
  • Condition that affects weight or body makeup, such as Cushing's syndrome or uncontrolled thyroid disease
  • Another active cancer (other than non-melanoma skin cancer)
  • Not fluent in English

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • INTERVENTION PARTICIPANTS: Age 18 or older
  • INTERVENTION PARTICIPANTS: Diagnosed with histologically confirmed prostate cancer
  • INTERVENTION PARTICIPANTS: Received \>= 6 months of ADT any time in the past 10 years
  • INTERVENTION PARTICIPANTS: Completed radiotherapy, chemotherapy and/or surgery \> 6 weeks prior to
  • INTERVENTION PARTICIPANTS: No intent to start adjuvant chemotherapy or radiotherapy within 6 months of enrollment
  • INTERVENTION PARTICIPANTS: Overweight or obese (body mass index \> 25 kg/m2 to BMI ≤ 50)
  • INTERVENTION PARTICIPANTS: Evidence of frailty by meeting three or more of the following frailty criteria: weakness, slowness, fatigue, inactivity, and/or illness
  • INTERVENTION PARTICIPANTS: Not currently engaging in structured diet or resistance strength training exercise program
  • INTERVENTION PARTICIPANTS: Willing to be randomized into either study arm and adhere to study protocol
  • INTERVENTION PARTICIPANTS: Home internet sufficient for videoconferencing
  • INTERVENTION PARTICIPANTS: Signed informed consent
  • IMPLEMENTATION PARTICIPANTS: Be a key stakeholder (i.e., healthcare provider or administrative, or intervention participant [completers, partial completers, or no participation])
  • IMPLEMENTATION PARTICIPANTS: Verbal informed consent following receipt of an information sheet

Who cannot take part

  • INTERVENTION PARTICIPANTS: Currently taking or have taken creatine supplement in the month preceding baseline creatine testing
  • INTERVENTION PARTICIPANTS: Health or medical condition that affects weight status/body composition (e.g., Cushing's syndrome, uncontrolled hyper-/hypo- thyroidism)
  • INTERVENTION PARTICIPANTS: Active malignancy (other than non-melanoma skin cancer)
  • INTERVENTION PARTICIPANTS: Unintentional weight loss \> 5% within the last year
  • INTERVENTION PARTICIPANTS: Contraindication to moderate intensity exercise
  • INTERVENTION PARTICIPANTS: Not fluent in English and therefore incapable of answer survey questions, following directions during exercise or performance testing, and providing informed consent in English

Where in United States

  • OHSU Knight Cancer InstitutePortland, United StatesContact: Kerri Winters-StoneTaking people

About the trial

What the trial wants to find out

This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.

The 2 groups in the trial

  • Arm I (iLIVE)Treatment being tested

    Patients receive online access to an interactive weight loss website and participate in online group based resistance training sessions (iLIVE) on study. Patients also use a Fitbit fitness tracker and Aria smart scale while on study.

    Treatment: Internet-Based Exercise Intervention and Internet-Based Diet Intervention

  • Arm II (usual care)Existing treatment, for comparison

    Patients receive usual care with access to online survivorship and exercise recommendations and use a Fitbit fitness tracker and Aria (registered trademark) smart scale while on study.

    Treatment: Education Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)
Plain-language title
Online Diet and Exercise Program for Men with Prostate Cancer on Hormone TherapyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
8 May 2026